Get the Stockscreener App
2.76
1.43%
-0.04
Regulus Therapeutics Inc Stock (RGLS) Forecast
The Regulus Therapeutics Inc (RGLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.1316, representing a +49.70% increase from the current price of $2.76. The highest analyst price target is $3.9758, and the lowest is $4.2875.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RGLS Price Target
Average 6.1456
(+122.67% Upside)
Is Regulus Therapeutics Inc (RGLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 79.92 | Sell |
| STOCH(9,6) | 92.21 | Sell |
| STOCHRSI(14) | 92.22 | Sell |
| MACD(12,26) | 0.2894 | Buy |
| ADX(14) | 53.15 | Buy |
| William %R | -10.14 | Sell |
| CCI(14) | 181.44 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.208
Buy
|
2.3004
Buy
|
| MA20 |
1.9693
Buy
|
2.0416
Buy
|
| MA50 |
1.5905
Buy
|
1.7288
Buy
|
| MA100 |
1.4995
Buy
|
1.6007
Buy
|
| MA200 |
1.5435
Buy
|
1.6103
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, RGLS could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on RGLS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 79.92 indicates that RGLS is overbought. This suggests that RGLS price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 92.21 indicates that RGLS is oversold. This means that RGLS price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 92.22 indicates that RGLS is oversold. This suggests that RGLS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 53.15 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 181.44 indicates that RGLS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RGLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Regulus Therapeutics Inc financial reports and earnings history, Regulus Therapeutics Inc (RGLS) stock could reach $9.7988 by 2030, $10.77 by 2040 and $26.87 by 2050. See the projected annual prices until 2050 of the Regulus Therapeutics Inc stock below:
- Regulus Therapeutics Inc (RGLS) is expected to reach an average price of $4.3488 in 2035, with a high prediction of $4.6568 and a low estimate of $4.4684. This indicates an $57.57% rise from the last recorded price of $2.76.
- Regulus Therapeutics Inc (RGLS) stock is projected to chart a bullish course in 2040, with an average price target of $10.17, representing an $268.42% surge from its current level. The forecast ranges from a conservative $10.28 to a sky-high $10.77.
- Our analysts predict Regulus Therapeutics Inc (RGLS) to jump 530.49% by 2045, soaring from $17.48 to an average price of $17.40, potentially reaching $17.44. While $17.48 is the low estimate, the potential upside is significant.
- Regulus Therapeutics Inc (RGLS) stock is expected to climb by 2050, reaching an average of $26.15, a $847.48% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.87 and $26.28, respectively, highlighting the market's uncertainty.
Regulus Therapeutics Inc Stock (RGLS) Year by Year Forecast
Regulus Therapeutics Inc Stock (RGLS) Price Forecast for 2025
Regulus Therapeutics Inc Stock (RGLS) is expected to reach an average price of $4.0544 in 2025, with a high prediction of $7.9456 and a low estimate of $0.1631. This indicates an +46.90% rise from the last recorded price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $4.1655 | $4.2875 | $3.9758 | +50.92% |
| June, 2025 | $2.882 | $3.371 | $3.8302 | +4.42% |
| July, 2025 | $0.1764 | $0.5264 | $1.6439 | -93.61% |
| August, 2025 | $0.3789 | $1.7089 | $1.101 | -86.27% |
| September, 2025 | $1.4734 | $1.0517 | $3.4774 | -46.61% |
| October, 2025 | $3.7489 | $2.4393 | $3.0469 | +35.83% |
| November, 2025 | $3.0914 | $3.0766 | $3.0187 | +12.01% |
| December, 2025 | $3.3758 | $2.8931 | $2.6228 | +22.31% |
Regulus Therapeutics Inc Stock (RGLS) Price Forecast for 2026
The predicted value for Regulus Therapeutics Inc (RGLS) in 2026 is set at an average of $7.8492. Estimates vary from a peak of $15.70 to a trough of $0.00185, indicating an +184.39% surge from the present price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.6023 | $2.1563 | $2.5567 | -41.95% |
| February, 2026 | $4.3472 | $0.182 | $5.618 | +57.51% |
| March, 2026 | $4.1636 | $3.2763 | $7.5763 | +50.86% |
| April, 2026 | $10.91 | $3.4928 | $12.11 | +295.26% |
| May, 2026 | $10.93 | $2.4675 | $15.70 | +295.86% |
| June, 2026 | $6.4422 | $5.7839 | $11.05 | +133.41% |
| July, 2026 | $1.5878 | $0.9438 | $8.1795 | -42.47% |
| August, 2026 | $3.3043 | $1.5179 | $7.7043 | +19.72% |
| September, 2026 | $0.6708 | $0.00185 | $3.4625 | -75.69% |
| October, 2026 | $0.4813 | $0.011 | $1.0083 | -82.56% |
| November, 2026 | $1.0368 | $0.3046 | $1.1508 | -62.43% |
| December, 2026 | $0.2914 | $0.2202 | $2.0359 | -89.44% |
Regulus Therapeutics Inc Stock (RGLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Regulus Therapeutics Inc (RGLS) is $1.8734, with a high forecast of $3.7434 and a low forecast of $0.00337. This indicates an -32.12% decrease from the last price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.0661 | $0.00337 | $1.4961 | -25.14% |
| February, 2027 | $2.5667 | $1.7749 | $2.0387 | -7.01% |
| March, 2027 | $2.7621 | $2.5524 | $2.5031 | +0.07% |
| April, 2027 | $3.6056 | $2.8489 | $3.0686 | +30.64% |
| May, 2027 | $3.6101 | $3.7601 | $3.7434 | +30.80% |
| June, 2027 | $2.8915 | $3.5945 | $3.4996 | +4.77% |
| July, 2027 | $2.718 | $2.998 | $2.7332 | -1.52% |
| August, 2027 | $3.3316 | $2.7189 | $3.0326 | +20.71% |
| September, 2027 | $2.336 | $3.176 | $3.4743 | -15.36% |
| October, 2027 | $2.4195 | $2.5449 | $2.5486 | -12.34% |
| November, 2027 | $3.023 | $2.9654 | $3.1521 | +9.53% |
| December, 2027 | $3.3374 | $3.0239 | $3.3365 | +20.92% |
Regulus Therapeutics Inc Stock (RGLS) Price Forecast for 2028
In 2028, Regulus Therapeutics Inc (RGLS) is projected to reach an average price of $2.867, with a high projection of $3.471 and a low estimate of $2.2631. This indicates an +3.88% rise from the last price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.521 | $3.4783 | $3.471 | +27.57% |
| February, 2028 | $3.1245 | $3.0827 | $3.2118 | +13.21% |
| March, 2028 | $3.1289 | $3.0954 | $3.088 | +13.37% |
| April, 2028 | $2.8824 | $2.9524 | $3.0498 | +4.44% |
| May, 2028 | $3.1868 | $2.8642 | $2.9232 | +15.46% |
| June, 2028 | $2.8703 | $2.8899 | $2.9177 | +4.00% |
| July, 2028 | $2.6339 | $2.6639 | $2.7421 | -4.57% |
| August, 2028 | $2.7783 | $2.7674 | $2.7265 | +0.66% |
| September, 2028 | $2.9734 | $3.1035 | $3.0017 | +7.73% |
| October, 2028 | $2.4003 | $2.5906 | $2.5428 | -13.03% |
| November, 2028 | $2.3597 | $2.3371 | $2.3387 | -14.50% |
| December, 2028 | $2.0733 | $2.2631 | $2.1191 | -24.88% |
Regulus Therapeutics Inc Stock (RGLS) Price Forecast for 2029
The 2029 price forecast for Regulus Therapeutics Inc Stock (RGLS) is $3.4532 on average, with a high prediction of $6.88 and a low estimate of $0.0264. This represents an +25.12% increase from the previous price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.9977 | $2.0077 | $1.9768 | -27.62% |
| February, 2029 | $1.6312 | $2.0311 | $1.9684 | -40.90% |
| March, 2029 | $1.4647 | $1.7121 | $1.623 | -46.93% |
| April, 2029 | $1.7882 | $1.7974 | $1.6665 | -35.21% |
| May, 2029 | $1.5826 | $1.6526 | $1.6959 | -42.66% |
| June, 2029 | $1.3862 | $1.5062 | $1.4653 | -49.78% |
| July, 2029 | $1.3897 | $1.4352 | $1.3103 | -49.65% |
| August, 2029 | $1.2541 | $1.3615 | $1.2765 | -54.56% |
| September, 2029 | $0.9476 | $0.9867 | $1.125 | -65.67% |
| October, 2029 | $0.423 | $0.2319 | $1.4989 | -84.67% |
| November, 2029 | $0.0156 | $0.0556 | $0.7671 | -99.44% |
| December, 2029 | $8.08 | $0.0264 | $6.88 | +192.75% |
Regulus Therapeutics Inc Stock (RGLS) Price Forecast for 2030
Regulus Therapeutics Inc Stock (RGLS) is expected to reach an average price of $10.65 in 2030, with a high forecast of $14.25 and a low forecast of $7.0505. This signifies an +285.85% surge from the last price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.39 | $8.8025 | $9.7988 | +312.64% |
| February, 2030 | $7.9059 | $8.5559 | $8.1306 | +186.44% |
| March, 2030 | $14.30 | $8.8976 | $13.50 | +418.22% |
| April, 2030 | $14.00 | $14.48 | $14.25 | +407.21% |
| May, 2030 | $12.74 | $12.52 | $12.98 | +361.55% |
| June, 2030 | $12.63 | $13.13 | $12.99 | +357.57% |
| July, 2030 | $12.37 | $12.85 | $12.59 | +348.14% |
| August, 2030 | $12.61 | $11.91 | $11.31 | +356.87% |
| September, 2030 | $6.0087 | $7.7637 | $10.68 | +117.71% |
| October, 2030 | $10.05 | $7.0505 | $8.6175 | +264.15% |
| November, 2030 | $13.11 | $10.56 | $10.74 | +375.17% |
| December, 2030 | $13.54 | $13.64 | $13.11 | +390.60% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):